Relative IgG titres to specific viral proteins in acute and convalescent sera from patients with primary and recurrent genital herpes simplex virus type 2 (HSV-2) infections were determined using an immunoblot assay. Patients with recurrent genital infections generally had high titres of antibody reactive with two of the three major viral glycoproteins (gD and gG) as well as with several viral capsid proteins in both acute and convalescent sera. In contrast, patients experiencing primary genital HSV-2 infections exhibited marked differences in the polypeptide reactivity profiles of acute and convalescent sera. Of particular interest was the observation that the earliest and strongest antibody response was directed not against the viral glycoproteins but rather to an internal capsid protein(s) of HSV-2.
BishopO. A.,
GloriosoJ. C.,
SchwartzS. A.1983; Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. Journal of Experimental Medicine 157:1544–1561
BraunD. K.,
RoizmanB.,
PereiraL.1984; Characterization of post-translational products of herpes simplex virus gene 35 proteins binding to the surfaces of full capsids but not empty capsids. Journal of Virology 49:142–153
CarterV. C.,
SchafferP. A.,
TevethiaS. S.1981; The involvement of herpes simplex virus type 1 glycoproteins in cell mediated immunity. Journal of Immunology 126:1655–1660
EberleR.,
MouS.-W.1983; Relative titres of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera. Journal of Infectious Diseases 148:436–444
GravesM.,
GriffinD. E.,
JohnsonR. T.,
HirschR. L.,
DesorianoI. L.,
RoedenbeckS.,
VasibergA.1984; Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections. Journal of Virology 49:409–412
HeilmanC. J.,
ZweigM.,
StephensonJ. R.,
HamparB.1979; Isolation of a nucleocapsid polypeptide of herpes simplex virus types 1 and 2 possessing immunologically type-specific and cross-reactive determinants. Journal of Virology 29:34–42
HeineJ. W.,
SpearP. G.,
RoizmanB.1972; Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane. Journal of Virology 9:431–439
LawmanM. J. P.,
CourtneyR. J.,
EberleR.,
SchafferP. A.,
O’HaraM. K.,
RouseB. T.1980; Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infection and Immunity 30:451–461
NorrildB.,
ShoreS. L.,
NahmiasA. J.1979; Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides. Journal of Virology 32:741–748
PoewllK. L.,
BuchanA.,
SimC.,
WatsonD. H.1974; Type-specific protein in herpes simplex virus envelope reacts with neutralizing antibodies. Nature, London 249:360–361
PrestonV. G.,
CoatesJ. A. V.,
RixonF. J.1983; Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA. Journal of Virology 45:1056–1064
SimC.,
WatsonD. H.1973; The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2. Journal of General Virology 19:217–233